Biova Raises Egg Membrane Protein Level to 88%
The joint-health ingredient is produced using the company’s patented Hydro5 technology.
Biova LLC (Johnston, IA) has increased the standardized protein composition of its BiovaFlex water-soluble egg membrane ingredient to what it calls a market-leading 88%. The joint-health ingredient is produced using the company’s patented Hydro5 technology.
“The science indicates bioactivity is tied to the natural, non-denatured egg membrane matrix,” says Matt Stegenga, Biova’s director of marketing. “The primary composition of this matrix is a natural ratio of complex proteins including glycosaminoglycans, collagen, elastin, desmosine, isodesmosine, and transforming growth factor. So, yes, hitting uniform 88% protein across all BiovaFlex production is significant for us because it’s important for our customers’ products.”
PLT Health Solution's Bosewellia serrata extract granted updated license by Health Canada
August 27th 2024The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.
Cracking the code: Advancements in calcium absorption and nutritional understanding
July 23rd 2024Recent research conducted by ILSI U.S. and Canada – a global, nonprofit federation dedicated to advancing precompetitive research in the food, nutrition and health realms – and partially funded by Balchem, has shed light on how to improve predictions of Ca bioavailability across different food matrices.
